Patterson Companies (PDCO) Q4 Earnings Top, Sales Strong
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:02AM CDT
Patterson Companies Inc. (PDCO) reported adjusted earnings of 77 cents per share from continuing operations that beat the Zacks Consensus Estimate by a penny.
HYH: 32.58 (-0.80), BCR: 225.37 (-1.15), CNMD: 42.99 (+0.05), PDCO: 49.60 (-0.72)
CONMED Corporation Announces Quarterly Cash Dividend
BusinessWire - Wed May 25, 3:01PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2016 to all shareholders of record as of June 15, 2016.
CNMD: 42.99 (+0.05)
Veeva Systems (VEEV) Q1 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 9:26AM CDT
Notably, Veeva (VEEV) posted an average positive surprise of 15.98% over the last four quarters.
VEEV: 34.05 (-0.98), AIRM: 36.18 (-0.92), CNMD: 42.99 (+0.05), LH: 130.30 (-0.89)
Can Patterson Companies (PDCO) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:32AM CDT
Patterson Companies Inc. (PDCO) is set to announce fourth-quarter fiscal 2016 earnings on May 26.
AIRM: 36.18 (-0.92), CNMD: 42.99 (+0.05), PDCO: 49.60 (-0.72), LH: 130.30 (-0.89)
Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:42AM CDT
Becton, Dickinson and Company (BDX) recently announced the receipt of CE marking for its BD MAX Vaginal Panel.
BDX: 169.29 (-0.94), BCR: 225.37 (-1.15), MDT: 85.70 (-0.08), CNMD: 42.99 (+0.05)
DENTSPLY (XRAY) Tops Q1 Earnings & Sales, View Positive
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:19AM CDT
DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings of 69 cents per share in the first quarter of 2016 which beat the Zacks Consensus Estimate by 6 cents.
BCR: 225.37 (-1.15), VWR: 29.73 (-0.32), CNMD: 42.99 (+0.05), XRAY: 63.61 (-0.82)
Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 169.29 (-0.94), BCR: 225.37 (-1.15), ALGN: 78.83 (-0.86), CNMD: 42.99 (+0.05)
Conmed reports 1Q loss
Automated Insights - Wed Apr 27, 4:46PM CDT
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Wednesday reported a first-quarter loss of $2.3 million, after reporting a profit in the same period a year earlier.
CNMD: 42.99 (+0.05)
CONMED Corporation Announces First Quarter 2016 Financial Results
BusinessWire - Wed Apr 27, 3:01PM CDT
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the first quarter ended March 31, 2016.
CNMD: 42.99 (+0.05)
CONMED Corporation to Present at the Deutsche Bank 41st Annual Health Care Conference
BusinessWire - Wed Apr 13, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the Deutsche Bank 41st Annual Health Care Conference at 2:10 p.m. ET on Thursday, May 5, 2016 in Boston, MA.
CNMD: 42.99 (+0.05), DB: 15.74 (-0.97)
CONMED Corporation to Announce First Quarter 2016 Financial Results on April 27, 2016
BusinessWire - Wed Apr 06, 3:05PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the first quarter of fiscal year 2016 after the market close on Wednesday, April 27, 2016. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CNMD: 42.99 (+0.05)
CONMED Corporation Announces Annual Meeting of Shareholders
BusinessWire - Mon Mar 07, 7:00AM CST
CONMED Corporation (NASDAQ: CNMD) today announced that its Annual Meeting of Shareholders will be held at the Company's corporate offices, 525 French Road, Utica, NY on Wednesday, May 25, 2016, at 2:30 p.m. ET. Shareholders of record at the close of business on April 7, 2016 shall be entitled to vote at the 2016 Annual Meeting.
CNMD: 42.99 (+0.05)
Global Orthopedic Surgical Power Tools Market Growth of 2.59% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: CONMED, DePuy Synthes, Medtronic - Research and Markets
BusinessWire - Thu Mar 03, 2:45PM CST
Research and Markets (http://www.researchandmarkets.com/research/3b2wmv/global_orthopedic) has announced the addition of the "Global Orthopedic Surgical Power Tools Market 2016-2020" report to their offering.
MDT: 85.70 (-0.08), CNMD: 42.99 (+0.05)
CONMED Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
BusinessWire - Mon Feb 01, 3:01PM CST
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference at 8:05 a.m. ET on Thursday, February 11, 2016 in New York, NY.
CNMD: 42.99 (+0.05)
CONMED Beats Q4 Earnings & Sales, FY16 View Impressive
Zacks Equity Research - Zacks Investment Research - Thu Jan 28, 10:15AM CST
CONMED Corp (CNMD) reported adjusted earnings of 52 cents per share, which beat the Zacks Consensus Estimate by a penny.
DSCI: 3.96 (-0.03), STAA: 5.36 (-0.13), CNMD: 42.99 (+0.05), OCLS: 0.96 (unch)
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2015 Financial Results
BusinessWire - Wed Jan 27, 3:01PM CST
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the fourth quarter and fiscal year ended December 31, 2015.
CNMD: 42.99 (+0.05)
CONMED Corporation to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on January 27, 2016
BusinessWire - Fri Jan 15, 7:00AM CST
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the fourth quarter and fiscal year 2015 after the market close on Wednesday, January 27, 2016. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CNMD: 42.99 (+0.05)
Global Orthopedic Software Market Report 2015-2021
M2 - Thu Jan 14, 10:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/kwg4f5/global_orthopedic) has announced the addition of the "Global Orthopedic Software Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. Global orthopedic software market has huge scope and its products are widely adopted across all the geographies. Globally, the demand for orthopedic software products are expected to rise further due to increase in adoption of minimally invasive surgeries and implants. Rising life style oriented diseases such as arthritis, osteoporosis diabetes and so on are giving rise to minimally invasive surgeries. Technological advancement and innovation in global orthopedic software market has created huge scope for global players to enter the market. FDA clearances to orthopedic software are driving the global orthopedic software market. Global orthopedic software by product includes digital templating/pre-operative planning software, orthopedic electronic health record, orthopedic practice management market, orthopedic picture archiving and communication systems are adopted globally. Additionally, the global adoption of electronic health record in major hospitals, clinics and diagnostic centers enables the orthopedic software market to grow. Global orthopedic software market by application such as orthopedic surgery, joint replacement and so on is expected to grow at a good pace due to huge adoption of minimally invasive surgeries. In the present scenario the global orthopedic software market is undergoing rapid expansion with adoption of technological support and innovative approaches. Global orthopedic software market is expecting significant expansion in emerging economies such as China, India, Japan and Korea. The key driving forces for the global orthopedic software market are: Global rise in life style oriented diseases such as osteoporosis, arthritis and diabetes are driving the global orthopedic software market. Global rise in adoption of minimally invasive surgeries have created huge scope for global orthopedic software market. Global increase in disabilities and disorders are also giving rise to global orthopedic software market. Rise in incidence and prevalence rate of arthritis, knee injuries are expected to bring huge scope for global orthopedic software market. Innovation and technological advancement enables the global orthopedic software market to grow fast. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiling - Adler Ortho - Advanced biologics - Aesculap Inc - Arthorcare - Arthrex - Aspen medical products - Biomet Inc - Brainlab AG - ConforMIS corp - CONMED corporation - Corin - Covidien - Curemd - Geistlich surgery - Greenway Health - Healthfusion Inc. - Johnson & Johnson - Kinamed Inc - Materialise NV - Mckesson Corporation - Medstrat, Inc. - Medtronic Inc. - Nuortho surgical - OMNI life science - Orthofix - OrthoPro - Philips corporation - Quality Systems, Inc. - Siemens - Smith and nephew - Stryker - Zimmer holdings For more information visit http://www.researchandmarkets.com/research/kw...orthopedic
JNJ: 117.01 (+0.01), MDT: 85.70 (-0.08), MTLS: 6.85 (-0.18), CNMD: 42.99 (+0.05), QSII: 12.44 (+0.08)
CONMED (CNMD) Seals SurgiQuest Buy, Boosts Surgical Unit
Zacks Equity Research - Zacks Investment Research - Tue Jan 05, 9:10AM CST
CONMED Corporation (CNMD) recently announced the completion of its previously announced acquisition of SurgiQuest.
NXTM: 20.63 (-0.36), ABAX: 45.53 (-1.36), LMAT: 15.03 (-0.06), CNMD: 42.99 (+0.05)